Skip to main content
Top
Published in: Clinical and Experimental Nephrology 2/2008

01-04-2008 | Case Report

Clinical manifestations and analyses of the cytotoxic T-lymphocyte associated-4 gene in two Japanese families with systemic lupus erythematosus

Authors: Keisuke Sugimoto, Shinsuke Fujita, Hidehiko Yanagida, Yoshihiro Shimada, Nobutada Tabata, Kazuro Yagi, Mitsuru Okada, Tsukasa Takemura

Published in: Clinical and Experimental Nephrology | Issue 2/2008

Login to get access

Abstract

Although still incompletely understood, the etiology of systemic lupus erythematosus (SLE) is considered to involve both genetic and environmental factors. We encountered two boys with severe SLE from unrelated families and analyzed the gene that encodes cytotoxic T-lymphocyte-associated (CTLA)-4, a protein important in T-cell activation and immune tolerance. Abnormal function of the gene may participate in causation of autoimmune disease, including SLE. In family 1, a boy showed serious cardiovascular complications associated with heart failure, and his mother also had clinically active SLE, including nephritis. A boy in family 2 developed severe renal complications and peripheral vasculitis accompanied by disseminated petechiae in the lower extremities. His paternal grandfather had died from fibrinous pneumonia caused by SLE. They showed high SLE Disease Activity Index (SLEDAI) score. Analysis of the CTLA-4 gene indicated that the boy in family 1 and his mother and the boy in family 2 possess a GG genotype in CTLA-4 exon 1 at +49 together with a 106-bp fragment length of the 3′ untranslated region (UTR) in exon 4. No association with disease activity was found for polymorphism of the promoter region in exon 1 at −318 in either family. Disorders of the CTLA-4 gene, especially a GG genotype in exon 1 at +49 and/or 106-bp fragment length of the 3′UTR in exon 4, may be involved in early development of SLE in Japanese children, such as the boys described here.
Literature
1.
3.
go back to reference Vyse TJ, Kotzin BL. Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol. 1998;16:261–92.CrossRefPubMed Vyse TJ, Kotzin BL. Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol. 1998;16:261–92.CrossRefPubMed
4.
go back to reference Hashimoto H, Nishimura Y, Dong RP, Kimura A, Sasazuki T, Yamanaka K, et al. HLA antigens in Japanese patients with systemic lupus erythematosus. Scand J Rheumatol. 1994;23:191–4.CrossRefPubMed Hashimoto H, Nishimura Y, Dong RP, Kimura A, Sasazuki T, Yamanaka K, et al. HLA antigens in Japanese patients with systemic lupus erythematosus. Scand J Rheumatol. 1994;23:191–4.CrossRefPubMed
5.
go back to reference Duits AJ, Bootsma H, Derksen RHWM, Spronk PE, Kater L, Kallenberg CGM, et al. Skewed distribution og IgG Fc receptor Iia (CD 32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum. 1995;38:1832–6.CrossRefPubMed Duits AJ, Bootsma H, Derksen RHWM, Spronk PE, Kater L, Kallenberg CGM, et al. Skewed distribution og IgG Fc receptor Iia (CD 32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum. 1995;38:1832–6.CrossRefPubMed
6.
go back to reference Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest. 1996;98:1107–13.CrossRefPubMedPubMedCentral Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest. 1996;98:1107–13.CrossRefPubMedPubMedCentral
7.
go back to reference Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG, Golstein P. A new member of the immunoglobulin superfamily-CTLA-4. Nature. 1987;328:267–70.CrossRefPubMed Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG, Golstein P. A new member of the immunoglobulin superfamily-CTLA-4. Nature. 1987;328:267–70.CrossRefPubMed
8.
go back to reference June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today. 1994;15:321–31.CrossRefPubMed June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today. 1994;15:321–31.CrossRefPubMed
9.
go back to reference Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MTM, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Registry BD, Tosi R, Pozzilli P, Todd JA. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with type I diabetes. Hum Mol Genet. 1996;5:1075–80.CrossRefPubMed Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MTM, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Registry BD, Tosi R, Pozzilli P, Todd JA. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with type I diabetes. Hum Mol Genet. 1996;5:1075–80.CrossRefPubMed
10.
go back to reference Yanagawa T, Hidaka Y, Guimaraes V, Soliman M DeGroot LJ. CTLA-4 gene polymorphism associated with Graves’ disease in a Caucasian population. J Clin Endocrinol Metab. 1995;80:41–5.PubMed Yanagawa T, Hidaka Y, Guimaraes V, Soliman M DeGroot LJ. CTLA-4 gene polymorphism associated with Graves’ disease in a Caucasian population. J Clin Endocrinol Metab. 1995;80:41–5.PubMed
11.
go back to reference Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M, Walfish PG, Usadel KH, Badenhoop K. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto’s thyroiditis and Addison’s disease. J Clin Endocrinol Metab. 1997;82:4130–2.PubMed Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M, Walfish PG, Usadel KH, Badenhoop K. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto’s thyroiditis and Addison’s disease. J Clin Endocrinol Metab. 1997;82:4130–2.PubMed
12.
go back to reference Waterhouse P, Pnninger JM, Timms Emma, Wakeham A, Shainian A, Lee KP, Thompson CB, Griesser H, Mak TW. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science. 1995;270:985–8.CrossRefPubMed Waterhouse P, Pnninger JM, Timms Emma, Wakeham A, Shainian A, Lee KP, Thompson CB, Griesser H, Mak TW. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science. 1995;270:985–8.CrossRefPubMed
13.
go back to reference Takiguchi M, Murakami M, Nakagawa I, Saito I, Hashimoto A, Ueda T. CTLA4 IgG gene delivery prevents autoantibody production and lupus nephritis in MRL/1pr mice. Life Sci. 2000;66:991–1001.CrossRefPubMed Takiguchi M, Murakami M, Nakagawa I, Saito I, Hashimoto A, Ueda T. CTLA4 IgG gene delivery prevents autoantibody production and lupus nephritis in MRL/1pr mice. Life Sci. 2000;66:991–1001.CrossRefPubMed
14.
go back to reference Wang X, Huang W, Mihara M, Sinha J, Davidson A. Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus etythematosus. J Immunol. 2002;168:2046–53.CrossRefPubMed Wang X, Huang W, Mihara M, Sinha J, Davidson A. Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus etythematosus. J Immunol. 2002;168:2046–53.CrossRefPubMed
15.
go back to reference Hochberg MC. The application of genetic epidemiology to systemic lupus erythematosus. J Rheumatol. 1987;14:867–9.PubMed Hochberg MC. The application of genetic epidemiology to systemic lupus erythematosus. J Rheumatol. 1987;14:867–9.PubMed
16.
go back to reference Takemura T, Hino S, Kuwajima H, Yanagida H, Okada M, Nagata M, Sasaki S, Barasch J, Harris RC, Yoshioka K. Induction of collecting duct morphogenesis in vitro by heparin-binding epidermal growth factor-like growth factor. J Am Soc Nephrol. 2001;12:964–72.PubMed Takemura T, Hino S, Kuwajima H, Yanagida H, Okada M, Nagata M, Sasaki S, Barasch J, Harris RC, Yoshioka K. Induction of collecting duct morphogenesis in vitro by heparin-binding epidermal growth factor-like growth factor. J Am Soc Nephrol. 2001;12:964–72.PubMed
17.
go back to reference Takemura T, Hino S, Okada M, Murata Y, Yanagida H, Ikeda M, Yoshioka K, Harris RC. Potential role of membrane bound heparin-binding epidermal growth factor-like growth factor (HB-EGF) in renal epithelial cell branching. Kidney Int. 2002;61:1968–79.CrossRefPubMed Takemura T, Hino S, Okada M, Murata Y, Yanagida H, Ikeda M, Yoshioka K, Harris RC. Potential role of membrane bound heparin-binding epidermal growth factor-like growth factor (HB-EGF) in renal epithelial cell branching. Kidney Int. 2002;61:1968–79.CrossRefPubMed
18.
go back to reference Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J Immunol. 1997;158:1989–93.PubMed Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J Immunol. 1997;158:1989–93.PubMed
19.
go back to reference Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992;35:630–40.CrossRefPubMed Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992;35:630–40.CrossRefPubMed
20.
go back to reference Ahmed S, Ihara K, Kanemitsu S, Nakashima H, Otsuka T, Tsuzuka K, Takeuchi T, Hara T. Association of CTLA-4 but not CD 28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatol. 2001;40:662–7.CrossRef Ahmed S, Ihara K, Kanemitsu S, Nakashima H, Otsuka T, Tsuzuka K, Takeuchi T, Hara T. Association of CTLA-4 but not CD 28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatol. 2001;40:662–7.CrossRef
21.
go back to reference Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol. 2001;19:225–52.CrossRefPubMed Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol. 2001;19:225–52.CrossRefPubMed
22.
go back to reference Tivol EA, Schweitzer AN, Sharpe AH. Costimulation and autoimmunity. Curr Opin Immunol. 1996;8:822–30.CrossRefPubMed Tivol EA, Schweitzer AN, Sharpe AH. Costimulation and autoimmunity. Curr Opin Immunol. 1996;8:822–30.CrossRefPubMed
23.
go back to reference Pullmann R Jr, Lukac J, Skerenova M, Rovensky J, Hybeniva J, Melus V, Celec S, Pullman R, Hyrdel R. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 1999;17:725–9.PubMed Pullmann R Jr, Lukac J, Skerenova M, Rovensky J, Hybeniva J, Melus V, Celec S, Pullman R, Hyrdel R. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 1999;17:725–9.PubMed
24.
go back to reference Liu MF, Liu HS, Wang CR, Lei HY. Expression of CTLA-4 molecule in peripheral blood T lymphocytes from patients with systemic lupus erythematosus. J Clin Immunol. 1998;18:392–8.CrossRefPubMed Liu MF, Liu HS, Wang CR, Lei HY. Expression of CTLA-4 molecule in peripheral blood T lymphocytes from patients with systemic lupus erythematosus. J Clin Immunol. 1998;18:392–8.CrossRefPubMed
25.
go back to reference Liu MF, Wang CR Lin LC, Wu CR. CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus. Lupus. 2001;10:647–9.CrossRefPubMed Liu MF, Wang CR Lin LC, Wu CR. CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus. Lupus. 2001;10:647–9.CrossRefPubMed
26.
go back to reference Heward J, Gordon C, Allahabadia A, Barnett AH, Franklyn JA, Gough SC. The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus. Ann Rheum Dis. 1999;58:193–5.CrossRefPubMedPubMedCentral Heward J, Gordon C, Allahabadia A, Barnett AH, Franklyn JA, Gough SC. The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus. Ann Rheum Dis. 1999;58:193–5.CrossRefPubMedPubMedCentral
27.
go back to reference Lee YH, Harley JB, Nath SK. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Hum Genet. 2005;116:361–7.CrossRefPubMed Lee YH, Harley JB, Nath SK. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Hum Genet. 2005;116:361–7.CrossRefPubMed
28.
go back to reference Gauss KA, Bunger PL, Crawford MA, McDermott BE, Swearingen R, Nelson-Overton LK, Siemsen DW, Kobayashi SD, DeLeo FR, Quinn MT. Variants of the 5′-untranslated region of human NCF2: expression and translational efficacy. Gene. 2006;366:169–79.CrossRefPubMed Gauss KA, Bunger PL, Crawford MA, McDermott BE, Swearingen R, Nelson-Overton LK, Siemsen DW, Kobayashi SD, DeLeo FR, Quinn MT. Variants of the 5′-untranslated region of human NCF2: expression and translational efficacy. Gene. 2006;366:169–79.CrossRefPubMed
29.
go back to reference Hughes TA. Regulation of gene expression by alternative untranslated region. Trends Genet. 2006;22:119–22.CrossRefPubMed Hughes TA. Regulation of gene expression by alternative untranslated region. Trends Genet. 2006;22:119–22.CrossRefPubMed
30.
go back to reference Sobczak K, Krzyzosiak WJ. Structural determinants of BRCA1 translational regulation. J Biol Chem. 2002;277:17349–58.CrossRefPubMed Sobczak K, Krzyzosiak WJ. Structural determinants of BRCA1 translational regulation. J Biol Chem. 2002;277:17349–58.CrossRefPubMed
31.
go back to reference Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, Walker A, Mack TM. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 1992;35:311–8.CrossRefPubMed Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, Walker A, Mack TM. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 1992;35:311–8.CrossRefPubMed
Metadata
Title
Clinical manifestations and analyses of the cytotoxic T-lymphocyte associated-4 gene in two Japanese families with systemic lupus erythematosus
Authors
Keisuke Sugimoto
Shinsuke Fujita
Hidehiko Yanagida
Yoshihiro Shimada
Nobutada Tabata
Kazuro Yagi
Mitsuru Okada
Tsukasa Takemura
Publication date
01-04-2008
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 2/2008
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-007-0019-0

Other articles of this Issue 2/2008

Clinical and Experimental Nephrology 2/2008 Go to the issue